Skip to main content

Table 3 (abstract P414). See text for description

From: 37th International Symposium on Intensive Care and Emergency Medicine (part 3 of 3)

 

Survivor (n = 19)

Non survivor (n = 23)

 

3 Months previous hospitalization

2/19 (10.5%)

9/23 (39,1%)

P = 0.054

Steroids use

3/19 (15.8%)

14/23 (60.9%)

P = 0.024

Septic shock

11/19 (57.9%)

15/23 (65.2%)

P = 0.045

SOFA (day 1)

8.65 ± 3.37

11.9 ± 3.37

P = 0.015

SAPS II (day 1)

57.58 ± 17.70

67.59 ± 20.99

P = 0.034

Charlson Score

3.05 ± 1.87

4.00 ± 1.87

Ns

Optimal empirical therapy

17/19 (89.5%)

20/23 (87%)

Ns

Previous carbapenems therapy

2/19 (10.5%)

9/23 (39.1%)

P = 0.081

Oral gentamicin decontamination

2/19 (21.1%)

0/23 (0%)

P = 0.093

Gentamicin therapy

6/14 (42.9%)

1/23 (4.3%)

P = 0.023

Fosfomycin therapy

5/14 (35.7%)

3/23 (13%)

P = 0.066

Gentamicin associated with other antibiotics

6/19 (31.6%)

15/23 (4.3%)

P = 0.072

  1. Legend : Clinical characteristics, therapy and outcomes of study population